Therapies to limit infarct size: Timing, dosage, and effectiveness: Postgraduate Medicine: Vol 86, No 3

Views

CrossRef citations to date

Altmetric

Preview

The first few hours after a heart attack are critical to patient outcome. During this period, the course of events can be altered by disrupting the clotting process. Drs Peterson and Emmot discuss current use of thrombolytic and nonthrombolytic therapies to limit infarct size and thus reduce the risk of death in acute myocardial infarction.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Therapies to limit infarct size

Timing, dosage, and effectiveness

Information for

Open access

Opportunities

Help and information

Therapies to limit infarct size

Timing, dosage, and effectiveness

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature